Patents Assigned to NANORA PHARMA INC.
  • Methods of delivering anionic agents in vivo using non-viral nanoparticle-based delivery systems
    Patent number: 11766486
    Abstract: The present invention concerns a polymeric material for the production of a non-viral nanoparticle. The polymeric material comprises (i) a hydrophilic linear polymer having a first end and a second end, (iii) a cross-linkable cationic polymer covalently bonded to the first end of the hydrophilic linear polymer, and (iii) at least one targeting/penetrating peptide covalently associated to the second end of the hydrophilic linear polymer. Also disclosed herein are nanoparticles produced with these polymeric material, processes for making the polymeric material and the nanoparticles as well as use of the nanoparticles.
    Type: Grant
    Filed: October 13, 2020
    Date of Patent: September 26, 2023
    Assignee: NANORA PHARMA INC.
    Inventors: Satya Prakash, Meenakshi Malhotra
  • Method of making peptide-tagged PEGylated chitosan nanoparticles
    Patent number: 10799601
    Abstract: The present invention concerns a polymeric material for the production of a non-viral nanoparticle. The polymeric material comprises (i) a hydrophilic linear polymer having a first end and a second end, (iii) a cross-linkable cationic polymer covalently bonded to the first end of the hydrophilic linear polymer, and (iii) at least one targeting/penetrating peptide covalently associated to the second end of the hydrophilic linear polymer. Also disclosed herein are nanoparticles produced with these polymeric material, processes for making the polymeric material and the nanoparticles as well as use of the nanoparticles.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: October 13, 2020
    Assignee: NANORA PHARMA INC.
    Inventors: Satya Prakash, Meenakshi Malhotra